Melbourne man Ralph Markham’s life was transformed by love and, later, a devastating cancer diagnosis. Now, he is hoping new ...
Liv Hospital has released a comprehensive overview of its diagnostic and therapeutic capabilities in Nuclear Medicine, outlining the technologies, clinical applications, and patient-care standards ...
The Article by Tamim Niazi and colleagues1 on the Prostate Cancer Study 9 (PCS-9) investigated stereotactic body radiotherapy ...
Recent polling shows oncologists changing inclination in treatment for mHSPC based on tolerability profiles.
HER back pain was so debilitating she couldn’t sleep and had to crawl to the bathroom. Even more frighteningly, she was ...
Osvyrti and Jubereq are FDA-approved denosumab biosimilars for osteoporosis and cancer-related skeletal events, ...
Accord BioPharma, Inc., the specialty division of Intas Pharmaceuticals, Ltd., focused on development of oncology, immunology ...
Global Prostate Cancer Diagnostics Market OverviewThe global prostate cancer diagnostics market is projected to grow at a CAGR of approximately 12% during the forecast period, driven by a combination ...
Profound Medical Celebrates The Hong Center’s 200th Independent TULSA Procedure for Prostate Disease
Renowned urologist Dr. Mark Hong sets new global benchmark for urologist-led, MRI-guided prostate treatment, leading a growing movement toward incision-free prostate therapy ...
NEW YORK – Radiopharm Theranostics on Tuesday said it was cleared by Australian regulators to begin a Phase I trial of its KLK3-targeting radiotherapeutic, RAD 402, for the treatment of metastatic or ...
Former President Joe Biden, 82, completed a round of radiation therapy for aggressive prostate cancer. He received treatment at Penn Medicine Radiation Oncology in Philadelphia. The diagnosis followed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback